Blume Capital Management, Inc. Gilead Sciences, Inc. Transaction History
Blume Capital Management, Inc.
- $428 Million
- Q4 2024
A detailed history of Blume Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Blume Capital Management, Inc. holds 3,520 shares of GILD stock, worth $366,361. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,520
Previous 3,520
-0.0%
Holding current value
$366,361
Previous $295,000
10.17%
% of portfolio
0.08%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...